SphingoTec GmbH, a pioneer in the development of innovative biomarkers for acute medical conditions, has proudly announced a successful funding round of $5 million. The funds will play a crucial role in advancing the company's groundbreaking work in diagnosing and managing acute heart failure, acute kidney injury, and circulatory shock. Established in 2002 by biomarker expert Dr. Andreas Bergmann, a former Chief Research Officer responsible for initiating the widely recognized sepsis biomarker Procalcitonin (B.R.A.H.M.S. PCT™), SphingoTec is committed to transforming patient management through cutting-edge technology. With this latest infusion of capital, SphingoTec plans to enhance its research and development efforts, enabling the creation of more precise biomarkers that not only provide critical insights for acute conditions but also predict health risks related to obesity, cardiovascular diseases, and breast cancer. The company’s innovative approach is designed to inform treatment strategies and preventatively address potential health crises, ultimately improving patient outcomes and healthcare efficiency. The collaboration with strategic investors will empower SphingoTec to accelerate its product pipeline and expand its influence within the biotech industry, reinforcing its mission to enhance healthcare through advanced diagnostic solutions. As the global healthcare landscape continues to evolve, this funding marks a significant milestone for SphingoTec as it strides toward a future where timely and precise medical interventions are accessible to all.
SphingoTec Secures $5 Million in Funding for Innovative Biomarker Development
Recently funded · €5.0MBiomarker
Get the full SphingoTec company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
